Xeris Biopharma (XERS) 2025 Outlook: Earnings & Pipeline
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Uncover various investment strategies designed to help you grow your wealth over time. Make informed investment decisions now.
19,314 articlesA thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
A Seoul woman is accused of using an AI chatbot to help plan two fatal motel visits, sparking questions about AI safe...
Investors are reassessing opportunities in firearm makers as policy shifts and demand cycles test the staying power o...
As Joby Aviation gears up for commercial flights in 2026, investors are weighing a bold ramp in production, regulator...
When a specialized media stock falls on earnings day, it’s a signal to dig deeper. This article explains why webtoon ...
In a surprise move, President Trump names Senator Markwayne Mullin to head the Department of Homeland Security. Mulli...
As 2026 budget cycles unfold, investors are rethinking how the weapons that built army legacy translate into today’s ...
Apple's pivot toward services could change how the stock is valued. This guide breaks down the thesis, risks, and a p...
Robinhood unveils a private-market fund designed for everyday investors to back late-stage startups, signaling a shif...
Autonomous AI agents are moving beyond chatbots to do complex tasks. This article explains why the agentic market cou...
Zevra Therapeutics stock zoomed after a strong earnings release, delivering revenue growth and a first GAAP profit. T...
Axiamatic has secured $54 million in new funding to scale its AI-powered transformation platform, aimed at curbing bu...